BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Singapore
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:+08
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Brisbane
BEGIN:STANDARD
TZOFFSETFROM:+1000
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Hobart
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Tokyo
BEGIN:STANDARD
TZOFFSETFROM:+0900
TZOFFSETTO:+0900
TZNAME:JST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Phoenix
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260621
DTEND;VALUE=DATE:20260622
DTSTAMP:20260506T014101
CREATED:20251016T031613Z
LAST-MODIFIED:20251016T031613Z
UID:10000207-1782000000-1782086399@melanoma.org.au
SUMMARY:Hervey Bay Half Marathon Festival 2026
DESCRIPTION:The Hervey Bay Half Marathon Festival offers runners a truly unique coastal experience\, set against the stunning backdrop of Queensland’s Fraser Coast. With sweeping ocean views\, tranquil beaches\, and an inviting esplanade lined with palms and cafés\, participants will be immersed in the laid-back charm and natural beauty of this coastal paradise. \nWhether you’re chasing a personal best or simply soaking up the scenery\, the course makes the perfect setting for all types of runners—from seasoned athletes to first-timers. \nWith a variety of distances on offer — Half Marathon – 21.1km | 10km | 5km run & 5km walk | 2km Fun Run & Walk — there’s something for everyone to experience the excitement of crossing the finish line along Hervey Bay’s iconic foreshore. \nWhen you nominate MIA as your charity of choice\, funds raised support our life-saving melanoma research\, so we can reach our mission of zero deaths from melanoma. \nMake sure you set up your fundraising page\, as well as registering for the event – both can be done at the link below. \nREGISTER NOW
URL:https://melanoma.org.au/event/hervey-bay-half-marathon-festival-2026/
CATEGORIES:Fundraiser,Running Events
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2025/10/Hervey-Bay-Marathon-Festival.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260625
DTEND;VALUE=DATE:20260628
DTSTAMP:20260506T014101
CREATED:20260505T061717Z
LAST-MODIFIED:20260505T061717Z
UID:10000286-1782345600-1782604799@melanoma.org.au
SUMMARY:ASCO Breakthrough
DESCRIPTION:ASCO Breakthrough is an annual Asia-Pacific oncology meeting offering novel research and expert\, multidisciplinary perspectives on the newest scientific findings\, clinical and technology advances\, and treatment approaches that are rapidly changing cancer care. Take part in insightful sessions\, case discussions\, and abstract presentations\, and join a community of like-minded professionals to contribute\, together\, toward conquering cancer. \nWhy Attend ASCO Breakthrough? \n\nAccess Global Science with Regional Perspectives\nConnect with the Global ASCO Community in Asia\nGain Insight to Enhance Your Clinical Practice\n\nProgram Overview \nSessions will cover a range of topics\, including: \n\nConfronting the Global Surge of Early-Onset Cancers\nA Discussion on What It Will Take to Make Clinical Artificial Intelligence a Reality at the Bedside\nAntibody-Drug Conjugates\nNew Immunotherapy Combination Strategies\nMinimal Residual Disease in 2026 and What Is On The Horizon\nAdvancing Equitable Oncology in the Asia-Pacific Region – Bridging Gaps With Common Sense\nCase-Based Sessions focused on Liver Cancer\, Cervical Cancer\, and Oral Cavity Cancers\n\nThe Program will also include scientific update sessions\, the presentations of new and novel scientific advances\, and opportunities for attendees to network and connect with each other to build meaningful partnerships. \nLocation: Raffles City Convention Centre\, Singapore \nKey Dates: \nConference dates: 25 – 27 June\, 2026 \nEarly registration deadline: 20 May\, 2026 at 11:59 PM (ET) \nFIND OUT MORE
URL:https://melanoma.org.au/event/asco_breakthrough/
LOCATION:Raffles City Convention Centre\, 80 Bras Basah Road\, Singapore\, 189560\, Singapore
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/ASCO-Breakthrough-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260707T170000
DTEND;TZID=Australia/Sydney:20260707T170000
DTSTAMP:20260506T014101
CREATED:20260505T055547Z
LAST-MODIFIED:20260505T055547Z
UID:10000290-1783443600-1783443600@melanoma.org.au
SUMMARY:RACP Research Awards and Career Grants
DESCRIPTION:Through the RACP Foundation\, we’re able to offer financial support to Fellows and trainees pursuing careers in medical research. Over 50 different fellowships\, scholarships and grants are available annually\, totalling over $2.5 million in funding. \nCareer Development Fellowships are intended for mid-career researchers who completed their research higher degree over 7 years ago and/or researchers who are not eligible for either Research Entry Scholarship or Research Establishment Fellowships. \nResearch Establishment Fellowships are available to Fellows and Advanced Trainees who want to establish themselves in a research career. \nResearch Entry Scholarships provide stipend support only and are to assist Fellows and Advanced Trainees who are: \n\nat the start of their research careers and about to enrol in a Masters\, PhD or equivalent research higher degree\nin the 1st or 2nd full-time equivalent year of their research degree.\n\n\nKey Dates\nApplications close: 30 June 2026\nApplications close (Research Entry Scholarships): 7 July 2026\nOutcomes advised: December 2026 \nSEE WEBSITE
URL:https://melanoma.org.au/event/racp-awards-grants/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/RACP-Awards-and-Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260714
DTEND;VALUE=DATE:20260729
DTSTAMP:20260506T014101
CREATED:20260401T234731Z
LAST-MODIFIED:20260407T235036Z
UID:10000282-1783987200-1785283199@melanoma.org.au
SUMMARY:MPA-MIA Community Webinar Series 2026
DESCRIPTION:Join us for an informative series of three live webinars for patients with melanoma and their carers. \nHosted by Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA)\, each week our free webinar will provide you with a rare opportunity to hear from medical experts and community members as they focus on a different topic of interest each week. The webinar will conclude with a Q&A panel discussion. \nThe webinars are held every Tuesday evening for three weeks. Please click on the registration link below for each webinar that you’d like to attend. \nNote that the webinars are held from 7pm to 8pm AEST.\nCost: Free \nWebinar One: ‘Your melanoma nurse: What they do and how they help’ \nWhen: Tuesday 14 July | 7 – 8pm AEST \nSpeakers: \n\nRebecca Johnson – National Melanoma Nurses Program Manager\nPeta Holly – Specialist Melanoma Telehealth Nurse\nA community member\n\nREGISTERWebinar Two: ‘Understanding endocrine side effects of immunotherapy’\nWhen: Tuesday 21 July | 7 – 8pm AEST \nSpeakers: \n\nDr Stephanie Zunder – Medical Oncologist\nDr Annabel Hayes – Endocrinologist\nAled Gaynor – Medical Oncology Clinical Nurse Consultant\nA community member\n\nREGISTERWebinar Three: ‘Understanding sentinel lymph node biopsies: Helping you decide’ \nWhen: Tuesday 21 July | 7 – 8pm AEST \nSpeakers: \n\nA/Prof Alexander van Akkooi – Surgical Oncologist\nShahn Coburn – Surgical Clinical Nurse Consultant\nA community member\n\nREGISTER
URL:https://melanoma.org.au/event/mpa-mia-community-webinar-series-2026/
CATEGORIES:Education,Patient Education
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/MIAE0367-MIA-_-MPA_WEB-BANNER_1200x675-series.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260714T170000
DTEND;TZID=Australia/Sydney:20260714T170000
DTSTAMP:20260506T014101
CREATED:20260505T055930Z
LAST-MODIFIED:20260505T055930Z
UID:10000291-1784048400-1784048400@melanoma.org.au
SUMMARY:MRFF National Critical Research Infrastructure
DESCRIPTION:The 2026 National Critical Research Infrastructure initiative invests in research infrastructure to ensure Australian researchers find innovative solutions to complex health problems in areas of unmet medical need. This grant opportunity has four streams. \nStream 1 – Innovation enablers\nAddress an area of unmet medical need by promoting the development and implementation of new research infrastructure by supporting development and/or expansion of research enablers such as biobanks\, tissue repositories\, novel platforms\, and secure health data environments to create valuable research resources. \nStream 2 – Digitisation of health care\nTranslate or implement innovative artificial intelligence technologies into health applications that: \n\nbenefit multiple health disciplines/areas\ninvolve consumers in the research journey to ensure the research is applicable to the needs of the Australian community; and\nincrease artificial intelligence workforce capacity and capability\, particularly in relation to health\, through cross-sector and interdisciplinary collaboration.\n\nStream 3 – Co-investment partnerships\nUtilise co-investment (cash only) with the research sector\, state and/or territory governments\, and industry\, in significant critical research infrastructure (e.g. facilities\, personnel and equipment): \n\nto support development of research capacity\, capability and/or effectiveness in an area of unmet medical need\, or\nto enable Australian research using new platforms\, systems and services in an area of unmet medical need.\n\nStream 4 – mRNA technology enablers\nLeverage and enhance emerging mRNA technologies\, platforms\, and/or equipment to accelerate development of mRNA-based vaccines and therapeutics in an area of unmet medical need. \nGrants to fund research infrastructure projects\, up to $3 million in Streams 1\, 2 and 4\, and up to $7 million in Stream 3. \nAn application may only be submitted to one of the above four streams. Applicants must specify the stream to which they are applying in their application. \n\n\n\nKey Dates\nApplications close: 14 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-research-infrastructure/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Critical-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260722T170000
DTEND;TZID=Australia/Sydney:20260722T170000
DTSTAMP:20260506T014101
CREATED:20260505T060230Z
LAST-MODIFIED:20260505T060230Z
UID:10000292-1784739600-1784739600@melanoma.org.au
SUMMARY:MRFF BioMedTech Incubator
DESCRIPTION:The MRFF 2026 BioMedTech Incubator Program provides grants of financial assistance to support medical research and medical innovation projects through the establishment of BioMedTech Incubators. \nThis grant is for an eligible organisation who can establish a working incubator\, to partner with Australian small and medium enterprises (SMEs) to progress new and innovative medical research projects through the early stages of development. \nThe 2026 BioMedTech Grant Opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative. \nThis opportunity looks to fund suitable organisations to identify\, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects that have commercial potential. \nThe intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers\, diagnostics\, therapeutics\, assistive devices and/or digital technologies that have progressed through the early stages of research and development to the point where they are ‘de-risked’ and attractive to private investment for commercialisation. \nApplicants may propose to support development of innovations in their area/s of strength (i.e. applicants are not required to propose a program that covers the breadth of the biomedtech sector). \nGrants of up to $33 million to establish BioMedTech Incubators. \n\nKey Dates\nApplications close: 22 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-incubator/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Incubator-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260723
DTEND;VALUE=DATE:20260726
DTSTAMP:20260506T014101
CREATED:20260331T012303Z
LAST-MODIFIED:20260331T012303Z
UID:10000278-1784764800-1785023999@melanoma.org.au
SUMMARY:ASDR Annual Scientific Meeting
DESCRIPTION:The Australasian Society for Dermatology Research (ASDR) is pleased to invite you to the ASDR 2026 Annual Scientific Meeting\, to be held in person from 23–25 July 2026 at the Westmead Innovation Centre\, Sydney\, Australia. The meeting will deliver a comprehensive scientific program featuring leading national and international experts\, highlighting recent progress and emerging directions in dermatology research. Key areas to be explored include: \n\nKeratinocyte and Squamous Cell Carcinomas\nMelanocyte/ Keratinocyte biology\nMicroenvironment\nFundamental Skin Research\nSkin immunology and immune disorders\nAutoimmune Disorders\nWound Healing and Stem Cells\nMelanoma and Pigmentation Disorders\nSkin Translational Research\n\nWe look forward to bringing together researchers\, clinicians\, and industry leaders to foster collaboration and discussion on the most innovative topics in dermatology research. \nLocation: Westmead Innovation Centre\, Sydney\, Australia \nKey Dates: \nAbstract Submission Deadline: 19 April 2026\nAbstract Outcomes: 15 May 2026\nEarly Bird Registration Deadline: 30 June 2026 at 23:59 AEST\nRegistration Deadline: 16 July 2026 at 23:59 AEST \nFIND OUT MORE
URL:https://melanoma.org.au/event/asdr-annual-meeting/
LOCATION:Westmead Innovation Centre\, Hawkesbury Rd\, Sydney\, NSW\, 2145\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/ASDR-ASM-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260724
DTEND;VALUE=DATE:20260726
DTSTAMP:20260506T014101
CREATED:20260129T022216Z
LAST-MODIFIED:20260129T023350Z
UID:10000238-1784851200-1785023999@melanoma.org.au
SUMMARY:Plastic Surgery Congress 2026
DESCRIPTION:Australian Society of Plastic Surgeons welcomes you to the 2026 Plastic Surgery Congress (PSC)\, where the future of plastic\, reconstructive\, and aesthetic surgery takes centre stage. \n​Taking place at the Sofitel Brisbane Central\, PSC 2026 promises a dynamic program packed with cutting-edge content\, world-class presentations\, and the latest global best practices. With two full days of medical education\, hands-on workshops\, and lively social events\, the Congress is designed to spark collaboration and professional growth. \n​In 2026\, delegates can expect an exceptional line-up of international and local faculty\, carefully curated to provide a truly bespoke educational experience. We have introduced a refreshed academic focus\, featuring topics not previously explored in depth at past congresses. These include burns\, peroneal reconstruction\, hands and brachial plexus surgery\, and aesthetics. And of course\, no congress held in Brisbane would be complete without a dedicated emphasis on skin cancer. \n​Expect an exceptional line-up of international and local experts who will showcase ground-breaking techniques and transformative ideas shaping the field today. \n​Key Dates \nAbstracts close: 9 February 2026 \nEarly bird registration closes: 22 April 2026 \nCongress Venue \nSofitel Brisbane Central \n249 Turbot Street Brisbane QLD 4000 AUSTRALIA​ \n​ \nFIND OUT MORE
URL:https://melanoma.org.au/event/psc_2026/
LOCATION:Sofitel Brisbane Central\, 249 Turbot Street\, Brisbane\, QLD\, 4000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/01/PSC_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260805
DTEND;VALUE=DATE:20260808
DTSTAMP:20260506T014101
CREATED:20260331T012114Z
LAST-MODIFIED:20260331T012114Z
UID:10000279-1785888000-1786147199@melanoma.org.au
SUMMARY:MOGA Annual Scientific Meeting
DESCRIPTION:The 2026 MOGA Annual Scientific Meeting (ASM) will bring together Australian medical oncologists to reflect on a timely theme: \nReimagining Cancer Care: Is Less Doing More? \nIn recent years\, oncology has found itself at a fascinating crossroads. With ever-deepening insights into tumour biology\, immunotherapy\, molecular profiling\, and patient-centred care\, we are beginning to ask a powerful and\, at times\, uncomfortable question: Are we sometimes doing too much? \nWe are now confronting the possibility that treatment de-escalation is not just a compromise\, but potentially a pathway to more humane\, precise\, and effective care. This conversation extends well beyond protocols and guidelines. It challenges us to think deeply about patient autonomy\, shared decision-making\, and what quality of life truly means in the era of personalised medicine. \nThis ASM will bridge disciplines and perspectives—from surgical oncology to medical and radiation oncology\, to palliative care and psychosocial support. We will consider not only clinical evidence\, but also the ethical\, logistical\, and emotional dimensions of doing less. We will look at emerging biomarkers and novel drug targets that allow us to fine-tune therapy like never before. Exploring what it means to personalise care in the truest sense—not just through science\, but through listening. \nLocation: RACV Royal Pines\, Gold Coast\, Australia \nKey Dates: \nEarly Bird Registrations Close: 14 June 2026\nAbstract Submissions Close: 14 June 2026\nAbstract Selection Advice: 3 July 2026\nAbstract Acceptance by Presenter: 10 July 2026\nTravel Award Applications Open: 3 July 2026\nTravel Award Applications Close: 10 July 2026\nTravel Award Recipient Notification: 17 July 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/moga-annual-scientific-meeting/
LOCATION:RACV Royal Pines Resort\, Ross Street\, Gold Coast\, Queensland\, 4217\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/MOGA-Asm-600-x-338-px-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260819T170000
DTEND;TZID=Australia/Sydney:20260819T170000
DTSTAMP:20260506T014101
CREATED:20260505T060732Z
LAST-MODIFIED:20260505T060732Z
UID:10000293-1787158800-1787158800@melanoma.org.au
SUMMARY:MRFF Genomics Health Futures
DESCRIPTION:The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \nStream 1 (TCR): develop genomic tools and technologies to identify genetic predisposition to cancer and improve screening and targeted intervention. Focus on increased access to genomic testing and on liquid biopsy. \nStream 2 (TCR): conduct scalable research to enhance novel gene discoveries\, increase diagnostic rates and enable disease modelling to support development of targeted therapies or prevention strategies. \nStream 3 (Incubator): develop novel methods for using polygenic risk scores to identify subgroups of the population at high risk of common and complex diseases (cardiovascular disease\, diabetes and other common and/or complex diseases). \nStream 4 (Incubator): develop novel methods for improving accuracy and usefulness of polygenic risk scores to stratify people with common cancers for surveillance and treatment (breast cancer\, colorectal cancer\, prostate cancer and other common cancers) \nStream 5 (TCR): undertake research to enhance or streamline uptake of clinical genomics into practice. \nStream 6 (Accelerator): develop and maintain infrastructure to support research collaboration by enabling data sharing\, portability\, longevity and connectivity of analysis across Australia. Research conducted should address emerging ethical\, legal and social issues associated with the governance of clinical and genomic datasets with particular focus on the application of advanced analytics (e.g. AI) to enhance the diagnostic utility of genomics. \nApplicants must propose research that addresses these objectives and those of the Genomics Health Futures Mission as outlined in the Roadmap and Implementation Plan. \nKey Dates \n\nMinimum data due date: 22 July 2026\nApplications close: 19 August 2026\nIndicative funding status: Funding anticipated to be awarded from June 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-genomics-health-futures/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF-Genomics-Health-Futures600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260830
DTEND;VALUE=DATE:20260831
DTSTAMP:20260506T014101
CREATED:20251016T032249Z
LAST-MODIFIED:20251024T040143Z
UID:10000208-1788048000-1788134399@melanoma.org.au
SUMMARY:2026 TCS Sydney Marathon presented by ASICS
DESCRIPTION:Whether you’re chasing your debut or your next star\, the TCS Sydney Marathon presented by ASICS is your moment to shine. \nSydney is the bucket-list race that redefines what’s possible\, so come experience the place where the world comes to finish. \nWhen you nominate MIA as your charity of choice\, funds raised support our life-saving melanoma research\, so we can reach our mission of zero deaths from melanoma. \nMake sure you set up your fundraising page\, as well as registering for the event – both can be done at the link below. \nREGISTER NOW
URL:https://melanoma.org.au/event/2026-tcs-sydney-marathon-presented-by-asics/
CATEGORIES:Fundraiser,Running Events
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2025/06/TCS-Sydney-Marathon-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260912
DTEND;VALUE=DATE:20260917
DTSTAMP:20260506T014101
CREATED:20260331T012815Z
LAST-MODIFIED:20260331T012815Z
UID:10000256-1789171200-1789603199@melanoma.org.au
SUMMARY:European Congress of Pathology
DESCRIPTION:The European Society of Pathology (ESP) and the Swedish Society of Pathology are delighted to invite you to the 38th European Congress of Pathology (ECP 2026)\, to be held at Stockholmsmässan\, from 12 –16 September 2026\, in the heart of Sweden’s capital. \nECP 2026 will bring together more than 5\,000 participants from all over the world—pathologists\, clinicians\, researchers\, molecular biologists\, bioinformaticians\, medical scientists\, and industry partners. The meeting will provide an ideal opportunity for professional development\, networking\, to exchange insights\, and will demonstrate the commitment of the ESP to contributing to Pathology progress in the near future. \nThe motto of the congress – “Innovation Driving Excellence in Pathology” –acknowledges the significant improvement that pathology innovation has brought and continues to bring to diagnostics\, assessment of prognosis and therapy response prediction and clinical practice. The excellent programme prepared by the ESP working groups\, ESP-affiliated societies\, education and trainee committees\, and other collaborating societies will include keynote lectures\, slide seminars\, symposia\, and interactive workshops\, from internationally renowned speakers and leaders in their fields. There will be a special focus on digital pathology\, AI integration\, and emerging technologies that are transforming our field. \nLocation: Stockholmsmässan\, Stockholm\, Sweden \nKey Dates: \nAbstract submission deadline: 8 April 2026\nAbstract notifications: early June 2026\nRegistration and payment deadline for authors of accepted abstracts: 25 June 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/european-congress-of-pathology/
LOCATION:Stockholmsmässan\, Mässvägen 1\, Älvsjö\, 12530\, Sweden
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/ECP-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260916
DTEND;VALUE=DATE:20260919
DTSTAMP:20260506T014101
CREATED:20260505T062122Z
LAST-MODIFIED:20260505T062122Z
UID:10000287-1789516800-1789775999@melanoma.org.au
SUMMARY:ABNA Annual Conference
DESCRIPTION:ABNA’s Annual Conference “From Collection to Discovery: Enabling Research\, Accelerating Impact” will be held in Hobart\, 16-18 September 2026. \nThe star event in the annual ABNA calendar\, this meeting provides an opportunity to connect with biobankers and biospecimen scientists from around the world to discuss shared strategies to shape the future of biobanking. The 2026 program will once again foster professional growth and encourage a commitment to excellence through expert talks exploring novel approaches to traditional biospecimen science as well as and cutting-edge biobanking technology. \nEnjoy workshops\, special interest group meetings\, rapid fire presentations\, poster displays\, and elevator pitch presentations as well as a range of networking events including biobanker speed networking\, a site visit and gala dinner to facilitate collaborations with researchers\, policymakers\, corporate sponsors and industry leaders to drive innovation and partnership. \nDon’t miss this chance to engage with the Australasian Biobanking community in the stunning city of Hobart – home to a thriving research and education sector. See you there! \nLocation: Crown Plaza Hobart\, Tasmania \nKey Dates: \nAbstract submission deadline: 14 August 2026\nAbstract notifications: late August/early September 2026\nEarly bird registration deadline: 31 July 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/abna_conference/
LOCATION:Crowne Plaza Hobart\, 110 Liverpool Street\, Hobart\, Tasmania\, 7000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/ABNA_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261008
DTEND;VALUE=DATE:20261014
DTSTAMP:20260506T014101
CREATED:20260331T012601Z
LAST-MODIFIED:20260331T012601Z
UID:10000277-1791417600-1791935999@melanoma.org.au
SUMMARY:IAP Congress
DESCRIPTION:It is with great pleasure that we welcome you to the 2026 XXXVI Congress of the International Academy of Pathology in Fukuoka\, bringing together the most enthusiastic and dedicated scholars in the field of pathology. Our goal is to create a unique platform where the latest advancements\, challenges\, and debates in diagnostic and molecular pathology are shared and discussed. \nThis biennial international congress on pathology will be held jointly with the 72nd Autumn Annual Meeting of the Japanese Society of Pathology\, which is held annually in Japan. \nAs the theme of this year’s congress is “Vision for the Future”\, we would like to hold a joint session in the sense of a new challenge that is not bound by the conventional format for the continued development of IAP. Key topics in molecular pathology including spatial transcriptome analysis and artificial intelligence will be explored across various subspecialties\, reflecting the evolving landscape of our field. We will also provide the programs on basic issues in pathology such as the educational system and infectious diseases. \nLocation: Fukuoka International Congress Center\, Fukuoka Sunpalace\, Fukuoka\, Japan \nKey Dates: \nAbstract Submission Deadline: Friday 10 April 2026\, 17:00 (JST)\nYoung Pathologist Award Application & Abstract Submission: Friday 10 April 2026\, 17:00 (JST)\nIAP Bursary Abstract Submission: Friday 10 April 2026\, 17:00 (JST)\nIAP Bursary Application Deadline: Thursday 30 April 2026\nNotification of Acceptance: June 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/iap-congress/
LOCATION:Fukuoka International Congress Center\, 2-1 Sekijōmachi\, Fukuoka\, 8120032\, Japan
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/IAP-2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20261028
DTSTAMP:20260506T014101
CREATED:20260302T035935Z
LAST-MODIFIED:20260302T035935Z
UID:10000257-1792713600-1793145599@melanoma.org.au
SUMMARY:ESMO Congress
DESCRIPTION:The ESMO Congress is a highly influential global oncology meeting for clinicians\, researchers\, patient advocates\, journalists and healthcare industry representatives from all over the world. \nESMO 2026 will be a platform for breakthroughs in oncology research\, clinical practice and patient care. Participants can expect impactful new data\, interactive education\, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026\, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale. \nA comprehensive educational and scientific programme will foster the exchange and debate of translational cancer science\, highlight the first announcements of potentially practice-changing data\, and stimulate multidisciplinary discussions aimed at improving treatment options for patients. \nLearning objectives: \n\nTo stay informed about current approaches in cancer prevention\, screening\, and early detection\nTo gain insights into the latest advances in basic\, translational\, and clinical cancer research\nTo explore the clinical implications of scientific breakthroughs in cancer biology\, diagnostics\, and treatment\nTo be updated on state-of-the-art therapeutic strategies for patients with cancer\nTo examine the emerging role of artificial intelligence in cancer diagnosis\, research and therapy\n\nLocation: IFEMA Madrid\, Madrid\, Spain \nKey Dates: \nEarly Registration Deadline: 22 July 2026 at 23:59 CEST\nAbstract Submission Deadline: 12 May 2026 at 21:00 CEST\nLate-Breaking Abstract Submission Deadline: 8 September 2026 at 21:00 CEST\nConference Dates: 23 October 2026 – 27 October 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/esmo-congress/
LOCATION:IFEMA Madrid\, Avda. Del Partenon\, 5\, Madrid\, 28042\, Spain
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/ESMO_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261104
DTEND;VALUE=DATE:20261107
DTSTAMP:20260506T014101
CREATED:20260505T061045Z
LAST-MODIFIED:20260505T061045Z
UID:10000283-1793750400-1794009599@melanoma.org.au
SUMMARY:ESSO Congress
DESCRIPTION:The Annual Congress of the European Society of Surgical Oncology (ESSO) is the leading event in Europe dedicated to advancing surgical cancer care. \nBringing together oncology surgeons\, researchers\, and healthcare professionals from across the globe\, the ESSO Congress offers a dynamic platform for sharing cutting-edge research\, surgical innovations\, and multidisciplinary approaches to cancer treatment. \nWith a strong focus on education\, collaboration\, and excellence in patient outcomes\, the congress fosters dialogue\, drives progress\, and shapes the future of surgical oncology. \nWith the theme Surgical Oncology without Borders: Innovations and Challenges Worldwide\, we will explore the latest advancements\, global perspectives\, and shared challenges that shape the future of Surgical Oncology around the world. \nLocation: IFEMA Madrid\, Spain \nKey Dates: \nAbstract submission deadline: 6 May 2026\nAbstract review results: 6 July 2026\nEarly registration deadline: 19 August 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/esso_congress/
LOCATION:IFEMA Madrid\, Avda. Del Partenon\, 5\, Madrid\, 28042\, Spain
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/ESSO_2026_1-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261104
DTEND;VALUE=DATE:20261109
DTSTAMP:20260506T014101
CREATED:20260505T061518Z
LAST-MODIFIED:20260505T061518Z
UID:10000284-1793750400-1794182399@melanoma.org.au
SUMMARY:SITC Annual Meeting
DESCRIPTION:SITC 2026 is the premier international conference focused on cancer immunotherapy\, bringing together leaders from academia\, regulatory agencies\, government\, and industry for education\, scientific exchange\, and networking. \nThe conference provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy. \nWhy attend SITC 2026? \n\nCutting-edge sessions by IO experts (Don’t miss over 40 sessions on the latest IO research)\nIn-person networking opportunities with IO luminaries\nAccess the latest immuno-oncology research\n\nLocation: Phoenix Convention Center\, Phoenix\, Arizona\, United States \nKey Dates: \nRegular and early career investigator award abstract submission deadline: 25 June 2026\nAbstract notifications: 31 July 2026\nLate-breaking abstract submission deadline: 10 September 2026\nAbstract notifications: 28 September 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/sitc_meeting/
LOCATION:Phoenix Convention Center\, 100 N 3rd Street\, Phoenix\, AZ\, United States
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/SITC_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261111
DTEND;VALUE=DATE:20261114
DTSTAMP:20260506T014101
CREATED:20260331T011646Z
LAST-MODIFIED:20260331T011646Z
UID:10000281-1794355200-1794614399@melanoma.org.au
SUMMARY:COSA Annual Scientific Meeting
DESCRIPTION:We are honoured to co-convene the 2026 COSA Annual Scientific Meeting (ASM) to be held at the International Convention Centre (ICC) Sydney from Wednesday 11 to Friday 13 November 2026\, with pre-conference workshops being held on Tuesday 10 November. \nThe theme for the 2026 COSA ASM is The precision generation: From cancer prevention to personalised care. \n\n\n\n\n\n\n\n\n\n\nThis theme reflects how far cancer care has evolved; from a one-size-fits-all rigid approach\, to care that is increasingly tailored to the individual\, across the entire cancer journey. \nThe disease theme will have a strong focus on lung cancers\, alongside sessions addressing head and neck cancers\, early-onset cancers such as colorectal cancer\, and brain cancer\, including both primary and metastatic disease. As always\, equity will be embedded throughout the program\, reflecting COSA’s ongoing commitment to improving outcomes for all people affected by cancer. \nIt has been almost a decade since the COSA ASM was held in Sydney\, so we are excited to bring it back to showcase the remarkable advances that have transformed cancer care over this time\, including the molecular biomarker realm and the evolution of novel transformative therapeutics. \nAustralia has developed deep expertise across clinical care\, research and clinical trials\, implementation and policy\, and the program will highlight this local leadership alongside contributions from international experts in the fields of drug development\, precision oncology\, pharmacogenomics and palliative and supportive care. \n\n\n\n\n\nLocation: International Convention Centre (ICC)\, Sydney\, Australia \nKey Dates: \nDelegate Designed Symposia Submissions Close: 3 July 2026\nAbstract Submissions Close: 7 August 2026\nAbstract Decision Notification: 2 September 2026\nAbstract Acceptance by Presenter: 11 September 2026\nEarly Bird Registration Deadline: 11 September 2026\nPre-conference Workshops: 10 November 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/cosa-scientific-meeting/
LOCATION:ICC Sydney and Cockle Bay – Darling Harbour\, 14 Darling Dr\, Sydney\, NSW\, 2000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/Cosa-Asm-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20261111T170000
DTEND;TZID=Australia/Sydney:20261111T170000
DTSTAMP:20260506T014101
CREATED:20260331T013110Z
LAST-MODIFIED:20260331T013110Z
UID:10000276-1794416400-1794416400@melanoma.org.au
SUMMARY:NHMRC Partnership Projects
DESCRIPTION:The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions\, undertake research\, interpret the findings and implement the findings into policy and practice. \n\nPartnership Projects create partnerships among decision makers\, policy makers\, managers\, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery\, organisation\, funding and access to health services. \nPartnership Projects will support collaborations\, within the Australian context\, that translate research evidence into health policy and health practice\, to improve health services and processes. \nThe objectives of the Partnership Project scheme are to: \n• Meet the need for more effective integration of research evidence into health policy and service delivery\n• Create partnerships among policy makers\, managers\, service providers and researchers\n• Provide support to answer often complex and difficult questions that policy makers\, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care\n• Be highly responsive to the priorities of government\, the community and health professionals\n• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations. \n\nKey Dates for Peer Review Cycle 2:\nApplications open: 19 March 2026\nNHMRC-approved Administering Institutions waiver due: 8 July 2026\nMinimum data due: 22 July 2026\nApplications close: 5 August 2026\nPeer review meetings: 17-19 November 2026 \nKey Dates for Peer Review Cycle 3:\nApplications open: 23 July 2026\nNHMRC-approved Administering Institutions waiver due: 14 October 2026\nMinimum data due: 28 October 2026\nApplications close: 11 November 2026\nPeer review meetings: 2-4 March 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-partnership-projects/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC-Partnership-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261119
DTEND;VALUE=DATE:20261122
DTSTAMP:20260506T014101
CREATED:20260302T042655Z
LAST-MODIFIED:20260302T042655Z
UID:10000258-1795046400-1795305599@melanoma.org.au
SUMMARY:Australasian Melanoma Conference
DESCRIPTION:The Australasian Melanoma Conference 2026 is a premier event for professionals involved in melanoma and skin cancer research\, diagnosis\, and clinical management. The conference will present new discoveries from basic science and explore cutting-edge paradigms in melanoma and skin cancer care. It is designed for clinicians\, researchers\, and healthcare professionals seeking the latest updates in the field and opportunities for networking and collaboration. \nThe AMC 2026 conference program will feature a broad range of speakers across multi disciplines and concurrent sessions under the key categories of: \n\nPrevention\nEarly Detection\nAdvanced Diseases\nSurvivorship\n\nLocation: Sofitel Melbourne on Collins\, Melbourne\, Australia \nKey Dates: \nConference Dates: 19 November 2026 – 21 November 2026\nEarly Bird Registration Deadline: 31 July 2026\nAbstract Submission Deadline: 17 April 2026 at 11:59 PM (AEST) \nFIND OUT MORE
URL:https://melanoma.org.au/event/amc-2026/
LOCATION:Sofitel Melbourne on Collins\, 25 Collins Street\, Melbourne\, Victoria\, 3000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/AMC-2026-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR